Therapy Areas: Vaccines
Russia's sovereign wealth fund to supply up to 35 million doses of its Sputnik V COVID-19 vaccine to Uzbekistan
25 September 2020 -

The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, has agreed to supply up to 35 million doses of the Sputnik V COVID-19 vaccine to Uzbekistan, CNN reported on Friday.

RDIF said in a statement that upon approval by Uzbekistan's regulators, up to 10 million doses of the COVID-19 vaccine will be delivered to Tashkent-based pharmaceutical company Laxisam in 2020. As many as 25 million doses will be shipped in 2021.

CEO of RDIF, Kirill Dmitriev, said, "Sputnik V is based on the human adenoviral vector platform, which has been studied over decades and in more than 250 clinical studies, proving its safety and effectiveness," adding, "Supplies of the vaccine will ensure that medical specialists in the Republic of Uzbekistan have an advanced tool to combat the new coronavirus infection."

Reportedly, RDIF has already reached supply agreements with Mexico, Brazil and India.

According to CNN, Russia was the first country to approve a COVID-19 vaccine, but Moscow's claims were initially met with widespread concern and unanswered questions over the vaccine's safety, effectiveness and the speed at which it was developed.

Login
Username:

Password: